SKIN PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SKIN PHARMA
Largest movements
- Receivables within one year -€18,051
down €18,051 (-62.9%), from €28,675 to €10,624
of which Trade receivables: -€21,817
- Cash -€9,685
down €9,685 (-59.2%), from €16,358 to €6,673
mainly Debts after one year (-€70,546) and Tax, wage and social debts (-€17,205)
- Debts after one year -€70,546
down €70,546 (-11.9%), from €592,602 to €522,056
- Reserves +€51,034
up €51,034 (+22.8%), from €223,507 to €274,540
- Other debts +€23,224
up €23,224 (+69.8%), from €33,293 to €56,517
- Tax, wage and social debts -€17,205
down €17,205 (-84.9%), from €20,268 to €3,063
- Trade debts -€16,824
down €16,824 (-98.7%), from €17,050 to €226
- Gross operating margin -€11,702
down €11,702 (-10.8%), from €107,963 to €96,262
- Taxes -€2,875
down €2,875 (-16.8%), from €17,108 to €14,234
- Financial charges +€2,414
up €2,414 (+9.2%), from €26,292 to €28,706
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €961,268 | €933,565 | -€27,703 | -2.9% |
| Fixed assets | 21/28 | €913,735 | €913,735 | = | 0.0% |
| Financial fixed assets | 28 | €913,735 | €913,735 | = | 0.0% |
| Current assets | 29/58 | €47,534 | €19,830 | -€27,703 | -58.3% |
| Amounts receivable within one year | 40/41 | €28,675 | €10,624 | -€18,051 | -62.9% |
| Trade receivables | 40 | €28,675 | €6,858 | -€21,817 | -76.1% |
| Other amounts receivable | 41 | - | €3,766 | +€3,766 | |
| Cash at bank and in hand | 54/58 | €16,358 | €6,673 | -€9,685 | -59.2% |
| Deferred charges and accrued income | 490/1 | €2,501 | €2,533 | +€32 | +1.3% |
| Total equity and liabilities | 10/49 | €961,268 | €933,565 | -€27,703 | -2.9% |
| Equity | 10/15 | €228,507 | €279,540 | +€51,034 | +22.3% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €223,507 | €274,540 | +€51,034 | +22.8% |
| Distributable reserves | 133 | €223,507 | €274,540 | +€51,034 | +22.8% |
| Amounts payable | 17/49 | €732,762 | €654,025 | -€78,737 | -10.7% |
| Amounts payable after more than one year | 17 | €592,602 | €522,056 | -€70,546 | -11.9% |
| Financial debts | 170/4 | €592,602 | €522,056 | -€70,546 | -11.9% |
| Amounts payable within one year | 42/48 | €138,276 | €130,352 | -€7,924 | -5.7% |
| Current portion of amounts payable after more than one year | 42 | €67,665 | €70,546 | +€2,880 | +4.3% |
| Trade debts | 44 | €17,050 | €226 | -€16,824 | -98.7% |
| Suppliers | 440/4 | €17,050 | €226 | -€16,824 | -98.7% |
| Taxes, remuneration and social security | 45 | €20,268 | €3,063 | -€17,205 | -84.9% |
| Taxes | 450/3 | €20,268 | €3,063 | -€17,205 | -84.9% |
| Other amounts payable | 47/48 | €33,293 | €56,517 | +€23,224 | +69.8% |
| Accrued charges and deferred income | 492/3 | €1,883 | €1,616 | -€267 | -14.2% |
| Other operating charges | 640/8 | €1,413 | €1,455 | +€42 | +2.9% |
| Gross operating margin | 9900 | €107,963 | €96,262 | -€11,702 | -10.8% |
| Operating profit (loss) | 9901 | €106,550 | €94,807 | -€11,743 | -11.0% |
| Financial charges | 65/66B | €26,292 | €28,706 | +€2,414 | +9.2% |
| Recurring financial charges | 65 | €26,292 | €28,706 | +€2,414 | +9.2% |
| Profit (loss) for the period before taxes | 9903 | €80,258 | €66,100 | -€14,157 | -17.6% |
| Income taxes | 67/77 | €17,108 | €14,234 | -€2,875 | -16.8% |
| Profit (loss) for the period | 9904 | €63,149 | €51,867 | -€11,283 | -17.9% |
| Profit (loss) for the period to be appropriated | 9905 | €63,149 | €51,867 | -€11,283 | -17.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.